VINC

Vincerx Pharma Inc · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website vincerx.com
Employees(FY) 41
ISIN US92731L1061

Performance

+11.95%

-24.11%

-70.38%

-65.48%

-82.45%

YTD

-68.04%

Profile

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.

Advanced Technical Analysis

Technical Analysis of VINC 2024-12-20

The stock indicators reflect a predominantly bearish sentiment, with the Moving Average Score at 16 indicating strong downward pressure, while the Oscillators Score of 56 suggests a neutral stance. Overall, the Technical Score of 36 reinforces the bearish outlook, signaling caution for potential investors.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of VINC

Stock Rank

Recent News & Updates

2024-12-04 17:50
Vincerx Pharma announces workforce reduction of 55%, cost-control measures(Yahoo Finance)
2024-12-03 17:45
Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943(Globenewswire)
2024-11-11 20:00
Vincerx Pharma Reports Third Quarter 2024 Financial Results(Globenewswire)
2024-10-10 00:00
What Makes Vincerx Pharma (VINC) a New Buy Stock(Yahoo Finance)
2024-10-07 04:05
Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates(Globenewswire)
2024-08-08 04:30
Vincerx Pharma Reports Second Quarter 2024 Financial Results(Globenewswire)
2024-06-29 08:50
Why Is Applied Therapeutics, Inc. (APLT) the Best Biotech Penny Stock to Buy Now?(Insidermonkey)
2024-06-29 08:48
Are Analysts Bullish on Annexon, Inc. (ANNX) Right Now?(Insidermonkey)
2024-06-29 08:45
C4 Therapeutics, Inc. (CCCC): Is This the Best Biotech Penny Stock to Buy Now?(Insidermonkey)
2024-06-29 08:43
Why Did Analysts Give Alector, Inc. (ALEC) a Moderate Buy Rating?(Insidermonkey)
2024-06-29 08:40
Is Editas Medicine, Inc. (EDIT) One of the Best Biotech Penny Stocks to Buy Now?(Insidermonkey)
2024-06-29 08:37
Why Did Inozyme Pharma, Inc. (INZY) Get a Strong Buy Rating from Analysts?(Insidermonkey)
2024-06-29 08:35
Did Savara Inc. (SVRA) Receive a Good Rating from Wall Street Analysts in Q1?(Insidermonkey)
2024-06-29 08:32
Biomea Fusion, Inc. (BMEA): Why Did Analysts Give This Biotech Penny Stock a Moderate Buy Rating?(Insidermonkey)
2024-06-29 08:28
Is Black Diamond Therapeutics, Inc. (BDTX) a Good Biotech Penny Stock to Buy Right Now?(Insidermonkey)
2024-06-29 08:26
Vigil Neuroscience, Inc. (VIGL): Is This the Best Biotech Penny Stock to Buy Now?(Insidermonkey)
2024-06-29 06:30
10 Best Biotech Penny Stocks to Buy Now(Insidermonkey)
2024-06-27 00:00
Vincerx Pharma (VINC) Moves to Buy: Rationale Behind the Upgrade(Zacks)
2024-05-14 09:54
VINC Stock Earnings: Vincerx Pharma Misses EPS for Q1 2024(Investorplace)
2024-05-14 04:15
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-04-26 00:27
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants(Globenewswire)
2024-04-25 18:35
Vincerx Pharma Prices Public Offering of Shares, Warrants(Yahoo Finance)
2024-04-25 04:01
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants(Globenewswire)
2024-04-09 01:34
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study(Zacks)
2024-04-09 00:29
Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?(Yahoo Finance)
2024-04-08 20:40
Why Is Vincerx Pharma (VINC) Stock Down 64% Today?(Investorplace)
2024-04-08 04:30
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024(Globenewswire)
2024-04-01 19:53
VINC Stock Earnings: Vincerx Pharma Beats EPS for Q4 2023(Investorplace)
2024-03-31 20:00
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024(Globenewswire)
2024-03-29 04:51
Vincerx Pharma Inc (VINC) Reports Q4 and Full Year 2023 Financials: A Close Look(Yahoo Finance)

Page 1 of 4

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.